ITRM vs TXN · rev $390.0K vs P/E 52, rev $17.68B
Iterum Therapeutics PLC (ITRM) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
ITRM currently screens at market cap $38.6M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the ITRM and TXN stock pages for the full models.
Not investment advice.